NUP155 and glioblastoma: Analysis of NUP155 protein expression using the UALCAN database revealed that the NUP155 expression levels in head and neck squamous cell carcinoma (HNSC), glioblastoma multiforme (GBM), colon cancer, lung adenocarcinoma (LUAD), hepatocellular carcinoma (HCC), and clear cell renal cell carcinoma (RCC) were significantly upregulated when compared with those in the corresponding non-cancerous tissues (Fig. 2A).